Infusión continua de diazepam para el manejo de estado epiléptico refractario

González Astiazarán, Adalberto; Ruiz García, Matilde; Irigoyen Maldonado, Carmen; Ceja Moreno, Hugo.
Acta pediátr. Méx ; 15(4): 198-202, jul.-ago. 1994. tab
Artículo en Español | LILACS | ID: lil-177239

Documentos relacionados

  1. Can in vitro studies aid in the development and use of antiseizure therapies? A report of the ILAE/AES Joint Translational Task Force.
  2. Small-molecule caspase-1 inhibitor CZL80 terminates refractory status epilepticus via inhibition of glutamatergic transmission.
  3. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.
  4. [Initial Management of Status Epilepticus].
  5. Effect of intranasal and oral administration of levetiracetam on the temporal and spatial distributions of SV2A in the KA-induced rat model of SE.
  6. The role of ketamine-induced beta activity in the treatment of refractory status epilepticus. Is the EEG useful to determine responder's rate? A retrospective study.
  7. The electrophysiological and behavioral evaluation of the peptide hemopressin and cannabinoid CB1 receptor agonist and antagonist in pentylenetetrazol model of epilepsy in rats.
  8. Low threshold T-type calcium channels as targets for novel epilepsy treatments.
  9. Fructose 1,6-bisphosphate is anticonvulsant and improves oxidative glucose metabolism within the hippocampus and liver in the chronic pilocarpine mouse epilepsy model.
  10. Status epilepticus - time is brain and treatment considerations.